Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 24 | $76,754,210 |
| Sells | 12 | $1,773,502 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Mar 2025 18:32 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 17 Mar 2025 | Purchase | 56,277 | 12.2335 | 688,465 | I |
| 19 Mar 2025 18:32 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 18 Mar 2025 | Purchase | 113,880 | 12.6524 | 1,440,855 | I |
| 19 Mar 2025 18:32 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 19 Mar 2025 | Purchase | 58,306 | 12.6442 | 737,233 | I |
| 13 Mar 2025 19:35 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 11 Mar 2025 | Purchase | 320,690 | 11.4935 | 3,685,851 | I |
| 13 Mar 2025 19:35 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 12 Mar 2025 | Purchase | 292,934 | 12.2479 | 3,587,826 | I |
| 13 Mar 2025 19:35 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 13 Mar 2025 | Purchase | 468,356 | 12.4846 | 5,847,237 | I |
| 21 Jan 2025 17:34 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 16 Jan 2025 | Purchase | 121,681 | 13.885 | 1,689,541 | I |
| 21 Jan 2025 17:34 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 17 Jan 2025 | Purchase | 19,748 | 13.8747 | 273,998 | I |
| 15 Jan 2025 18:12 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 13 Jan 2025 | Purchase | 74,125 | 13.3946 | 992,875 | I |
| 15 Jan 2025 18:12 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 14 Jan 2025 | Purchase | 54,500 | 13.5645 | 739,265 | I |
| 15 Jan 2025 18:12 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 15 Jan 2025 | Purchase | 39,029 | 14.0068 | 546,671 | I |
| 10 Jan 2025 18:27 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 08 Jan 2025 | Purchase | 21,021 | 14.073 | 295,829 | I |
| 10 Jan 2025 18:27 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 10 Jan 2025 | Purchase | 204,098 | 13.126 | 2,678,990 | I |
| 06 Jan 2025 20:35 | ZYME | Zymeworks Inc | MOORE PAUL ANDREW | Chief Scientific Officer | 06 Jan 2025 | Sale | 9,792 | 14.9241 | 146,137 | D |
| 06 Jan 2025 20:35 | ZYME | Zymeworks Inc | MOORE PAUL ANDREW | Chief Scientific Officer | 06 Jan 2025 | Sale | 11,408 | 14.9241 | 170,254 | D |
| 06 Jan 2025 20:34 | ZYME | Zymeworks Inc | GALBRAITH KENNETH | Chair & CEO | 06 Jan 2025 | Sale | 23,885 | 14.9241 | 356,462 | D |
| 06 Jan 2025 20:34 | ZYME | Zymeworks Inc | GALBRAITH KENNETH | Chair & CEO | 06 Jan 2025 | Sale | 33,406 | 14.9241 | 498,554 | D |
| 06 Jan 2025 20:19 | ZYME | Zymeworks Inc | SMITH JEFFREY T L | EVP & Chief Medical Officer | 06 Jan 2025 | Sale | 11,110 | 14.9241 | 165,807 | D |
| 02 Jan 2025 17:51 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 30 Dec 2024 | Purchase | 58,988 | 14.4661 | 853,326 | I |
| 02 Jan 2025 17:51 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 31 Dec 2024 | Purchase | 146,501 | 14.5695 | 2,134,446 | I |
| 02 Jan 2025 17:51 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 02 Jan 2025 | Purchase | 157,880 | 14.7796 | 2,333,403 | I |
| 27 Dec 2024 18:41 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 24 Dec 2024 | Purchase | 11,958 | 14.1241 | 168,896 | I |
| 27 Dec 2024 18:41 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 26 Dec 2024 | Purchase | 16,692 | 14.3804 | 240,038 | I |
| 27 Dec 2024 18:41 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 27 Dec 2024 | Purchase | 101,659 | 14.4914 | 1,473,181 | I |
| 26 Dec 2024 12:46 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 19 Dec 2024 | Purchase A | 298,818 | 13.5289 | 4,042,679 | I |
| 26 Dec 2024 12:46 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 20 Dec 2024 | Purchase A | 704,488 | 14.0776 | 9,917,500 | I |
| 26 Dec 2024 12:46 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | Director , 10% | 23 Dec 2024 | Purchase A | 251,502 | 14.2508 | 3,584,105 | I |
| 08 Jan 2024 18:23 | ZYME | Zymeworks Inc | GALBRAITH KENNETH | Chair & CEO | 08 Jan 2024 | Sale | 5,706 | 11.2156 | 63,996 | D |
| 08 Jan 2024 18:23 | ZYME | Zymeworks Inc | GALBRAITH KENNETH | Chair & CEO | 05 Jan 2024 | Sale | 18,198 | 10.6522 | 193,849 | D |
| 08 Jan 2024 18:14 | ZYME | Zymeworks Inc | ASTLE CHRISTOPHER | SVP & Chief Financial Officer | 05 Jan 2024 | Sale | 4,563 | 10.6522 | 48,606 | D |
| 08 Jan 2024 18:14 | ZYME | Zymeworks Inc | ASTLE CHRISTOPHER | SVP & Chief Financial Officer | 08 Jan 2024 | Sale | 1,431 | 11.2156 | 16,050 | D |
| 08 Jan 2024 18:01 | ZYME | Zymeworks Inc | MOORE PAUL ANDREW | Chief Scientific Officer | 08 Jan 2024 | Sale | 2,339 | 11.2156 | 26,233 | D |
| 08 Jan 2024 18:01 | ZYME | Zymeworks Inc | MOORE PAUL ANDREW | Chief Scientific Officer | 05 Jan 2024 | Sale | 7,460 | 10.6522 | 79,465 | D |
| 11 Dec 2023 20:00 | ZYME | Zymeworks Inc | ASTLE CHRISTOPHER | SVP & Chief Financial Officer | 11 Dec 2023 | Sale | 886 | 9.1301 | 8,089 | D |
| 21 Jun 2023 16:04 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 16 Jun 2023 | Purchase | 3,350,000 | 8.12 | 27,202,000 | I |
| 30 Mar 2023 17:47 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 28 Mar 2023 | Purchase | 200,000 | 8 | 1,600,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)